STIEFEL LABORATORIES (U.K.) LTD
00831160Non-trading company
STIEFEL LABORATORIES (U.K.) LTD
Non-trading company
Contact & Details
Contact
Registered Address
79 New Oxford Street London WC1A 1DG United Kingdom
Full company profile for STIEFEL LABORATORIES (U.K.) LTD (00831160), an active company based in London, United Kingdom. Incorporated 15 Dec 1964. Non-trading company. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2014–2024)
Cash in Bank
N/A
Net Assets
£18.85M
Total Liabilities
£483.00k
Turnover
N/A
Employees
N/A
Debt Ratio
2%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 31 Dec Year End | 2023 31 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||||
|---|---|---|---|---|---|---|---|
No officers found | |||||||
No officers found
See all 27 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (3)
Glaxosmithkline Finance Plc
United Kingdom
- Ownership Of Shares 25 To 50 Percent,ownership Of Shares 25 To 50 Percent As Firm,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors
Setfirst Limited
United Kingdom
- Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent,right To Appoint And Remove Directors
Gsk Finance (no 2) Limited
Unknown
- Ownership Of Shares 25 To 50 Percent
- Voting Rights 25 To 50 Percent
- Right To Appoint And Remove Directors
Glaxosmithkline Finance Plc
Ceased 19 Aug 2021
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 24 Jun 2026 | Persons With Significant Control | Gsk Finance (No 2) Limited notified as a person with significant control | |
| 24 Jun 2026 | Persons With Significant Control | Cessation of Glaxosmithkline Finance Plc as a person with significant control on 19 Aug 2021 | |
| 24 May 2026 | Other | Audit exemption statement of guarantee by parent company for period ending 31/12/25 | |
| 24 May 2026 | Accounts | Annual accounts made up to 31 Dec 2025 | |
| 24 May 2026 | Other | Notice of agreement to exemption from audit of accounts for period ending 31/12/25 |
Gsk Finance (No 2) Limited notified as a person with significant control
Cessation of Glaxosmithkline Finance Plc as a person with significant control on 19 Aug 2021
Audit exemption statement of guarantee by parent company for period ending 31/12/25
Annual accounts made up to 31 Dec 2025
Notice of agreement to exemption from audit of accounts for period ending 31/12/25
Recent Activity
Latest Activity
Gsk Finance (No 2) Limited notified as a person with significant control
3 days ago on 24 Jun 2026
Cessation of Glaxosmithkline Finance Plc as a person with significant control on 19 Aug 2021
3 days ago on 24 Jun 2026
Audit exemption statement of guarantee by parent company for period ending 31/12/25
1 months ago on 24 May 2026
Annual accounts made up to 31 Dec 2025
1 months ago on 24 May 2026
Notice of agreement to exemption from audit of accounts for period ending 31/12/25
1 months ago on 24 May 2026